Breastfeeding, Avoiding Sugary Drinks Reduce Later Obesity Risk in Offspring
By Lori Solomon HealthDay Reporter
TUESDAY, March 18, 2025 -- Adequate breastfeeding (BF) and avoidance of sugary beverages in early life may reduce the risk for preadolescent obesity in infants exposed to gestational diabetes (GDM), according to a study published online March 12 in Obesity.
Baiyang Sun, Ph.D., from Kaiser Permanente Northern California in Pleasanton, and colleagues evaluated the impact of fetal exposure to GDM severity, infant BF, and sugary beverage intake on preadolescent overweight and obesity. The analysis included 850 mother-infant dyads exposed to GDM.
The researchers found that among preadolescents (aged 6 to 11 years), 17.6 percent had overweight, 18.2 percent had moderate obesity, and 7.6 percent had severe obesity. Compared with adequate BF and no sugar-sweetened beverages [SSB] and 100 percent fruit juice [FJ], the risk for obesity was higher for both inadequate BF with SSB/FJ intake (adjusted relative risk [aRR], 1.55) and for adequate BF with SSB/FJ intake (aRR, 1.50), independent of GDM severity and covariates. The risk for severe obesity was more than tripled with inadequate BF with SSB/FJ intake versus adequate BF without SSB/FJ intake (aRR, 3.80).
"BF adequacy and avoidance of sugary beverages in early life are modifiable lifestyle behaviors that may combat preadolescent obesity in infants exposed to GDM, suggesting potential longer-term benefits on child cardiometabolic health," the authors write.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted March 2025
Read this next
PFAS Exposure Linked to Teen Weight Regain After Bariatric Surgery
TUESDAY, Aug. 19, 2025 -- For adolescents, exposure to perfluoroalkyl and polyfluoroalkyl substances (PFAS) is associated with weight regain after bariatric surgery, according to...
Saliva Insulin Can Differentiate Hyperinsulinemia in Normoglycemic People
MONDAY, Aug. 18, 2025 -- Saliva insulin can differentiate between normal and hyperinsulinemic responses among normoglycemic adults with different body mass index (BMI) classes...
26.5 Percent of Adults With Diabetes Used GLP-1 RA Injectables in 2024
THURSDAY, Aug. 14, 2025 -- In 2024, 26.5 percent of adults with diagnosed diabetes used glucagon-like peptide 1 receptor agonist (GLP-1 RA) injectables, according to an August...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.